Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Incidence and characteristics of HBV reactivation in hematological malignant patients in south Egypt.

World journal of gastroenterology - 7 Oct 2013

Elkady Abeer, Aboulfotuh Sahar, Ali Elsayed Mostafa, Sayed Douaa, Abdel-Aziz Nashwa M, Ali Amany M, Murakami Shuko, Iijima Sayuki, Tanaka Yasuhito

Abstract excerpt

AIM: To investigate characteristics of hepatitis B virus (HBV) implicated in HBV reactivation in patients with hematological malignancies receiving immunosuppressive therapy. METHODS: Serum samples were collected from 53 patients with hematological malignancies negative for hepatitis B surface antigen (HBsAg) before the start of and throughout the chemotherapy course. HBV reactivation was diagnosed when the HBsAg...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Egypt
Share to Hematologic Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis B

Share to Hepatitis B Antibodies

Share to Hepatitis B Surface Antigens

Share to Hepatitis B virus

Share to Immunosuppressive Agents

Share to Virus Activation

Source

Open in PubMed Open full text

Identifiers

PMID: 24115819
DOI: 10.3748/wjg.v19.i37.6214
PMCID: PMC3787352

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Incidence and characteristics of HBV reactivation in hematological malignant patients in south Egypt.PMID 24115819Read ↗

Clinical characteristics and molecular analysis of hepatitis B virus reactivation in hepatitis B surface antigen-negative patients during or after immunosuppressive or cytotoxic chemotherapy.Semantic proximity Read ↗

Clinical and virological factors associated with hepatitis B virus reactivation in HBsAg-negative and anti-HBc antibodies-positive patients undergoing chemotherapy and/or autologous stem cell transplantation for cancer.Semantic proximity Read ↗

Detection of reactivation and genetic mutations of the hepatitis B virus in patients with chronic hepatitis B infections receiving hematopoietic stem cell transplantation.Semantic proximity Read ↗

Hepatitis B virus reactivation in patients receiving chemotherapy for malignancies: role of precore stop-codon and basic core promoter mutations.Semantic proximity Read ↗

Virological and clinical characteristics on reactivation of occult hepatitis B in patients with hematological malignancy.Semantic proximity Read ↗

Hepatitis B virus reactivation in patients undergoing cytotoxic chemotherapy for solid tumours: Precore/core mutations may play an important roleSemantic proximity Read ↗

Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression.Semantic proximity Read ↗

Fulminant hepatitis after allogenic bone marrow transplantation caused by reactivation of hepatitis B virus with gene mutations in the core promotor region.Semantic proximity Read ↗

Hepatitis B Virus Reactivation following Allogeneic Hematopoietic Stem Cell TransplantationSemantic proximity Read ↗

Reactivation from occult HBV carrier status is characterized by low genetic heterogeneity with the wild-type or G1896A variant prevalence.Semantic proximity Read ↗

Reactivation of latently infected hepatitis B virus in a leukemia patient with antibodies to hepatitis B core antigen.Semantic proximity Read ↗

Frequency of hepatitis B virus mutant in asymptomatic hepatitis B virus carriers receiving prophylactic lamivudine during chemotherapy for hematologic malignancies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.